Metastatic extraskeletal myxoid chondrosarcoma. Successful therapy with interferon alfa-2b

M Rubinger; I H Plenderleith; M Lertzman; A J Worth

doi:10.1378/chest.108.1.281

Metastatic extraskeletal myxoid chondrosarcoma. Successful therapy with interferon alfa-2b

Chest. 1995 Jul;108(1):281-2. doi: 10.1378/chest.108.1.281.

Authors

M Rubinger¹, I H Plenderleith, M Lertzman, A J Worth

Affiliation

¹ Department of Internal Medicine, University of Manitoba, Winnipeg, Canada.

PMID: 7606973
DOI: 10.1378/chest.108.1.281

Abstract

A patient with pulmonary metastatic extraskeletal myxoid chondrosarcoma (EMC), of unknown cause, responded dramatically to 16 months of therapy with interferon alfa-2b. This is the first report of a significant response of a patient with EMC to this novel treatment approach.

Publication types

Case Reports

MeSH terms

Chondrosarcoma / diagnostic imaging
Chondrosarcoma / drug therapy*
Chondrosarcoma / secondary*
Humans
Interferon alpha-2
Interferon-alpha / therapeutic use*
Lung Neoplasms / diagnostic imaging
Lung Neoplasms / drug therapy*
Lung Neoplasms / secondary*
Male
Middle Aged
Neoplasms, Unknown Primary*
Radiography
Recombinant Proteins
Treatment Outcome

Substances

Interferon alpha-2
Interferon-alpha
Recombinant Proteins